ArticleScientific reports2026
Characteristics of NK cells activation following IL-12, IL-15, IL-18 cytokines stimulation for preclinical purposes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Adoptive cell therapy is a promising strategy in cancer treatment, among which NK cell therapies represent an encouraging approach. Freshly isolated NK cells exhibit low cytolytic activity. Therefore, efficient activation of NK cells is essential to enhance their anti-cancer properties. The aim of this study was to compare ex vivo NK cells activation with commonly used cytokines, including IL-2, IL-12, IL-15, IL-18, or STING agonist, and to determine the most effective activation method. Our results indicate higher viability and expression of activating receptors and granzyme B in IL-15-treated NK cells. The addition of IL-12 to IL-15 augmented the production of IFN-γ and CCL3 in NK cells. However, incubation of NK cells with a cocktail of IL-12, IL-15, and IL-18 cytokines generated massive production of pro-inflammatory cytokines and a significant increase in activation marker CD69. We have also observed reduced viability of NK cells after incubation with STING agonist. NK cells activated with IL-12/IL-15, and IL-12/IL-15/IL-18 co-cultured with MHC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.